Updates on Chikungunya Epidemiology, Clinical Disease, and Diagnostics

Vector-Borne and Zoonotic Diseases

Volumn 15, Issue 4, 2015, Pages 223-230

  Sam, I Ching ^a   Kümmerer, Beate M ^b   Chan, Yoke Fun ^a   Roques, Pierre ^c,d   Drosten, Christian ^b   AbuBakar, Sazaly ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b UNIVERSITY OF BONN   (Germany)

^c INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^d UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Arthralgia; Chikungunya; Epidemiology; Genotype; Molecular diagnostics; Serologic tests; Signs and symptoms

Indexed keywords

ARTHRALGIA; ARTICLE; CHIKUNGUNYA; CHIKUNGUNYA VIRUS; DIAGNOSTIC TEST; FEVER; HUMAN; INCIDENCE; MOLECULAR DIAGNOSTICS; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; RASH; SEROLOGY; AEDES; AFRICA; ANIMAL; ASIA; CHIKUNGUNYA FEVER; DISEASE CARRIER; EPIDEMIC; EUROPE; GENETICS; GENOTYPE; IMMUNOLOGY; ISOLATION AND PURIFICATION; MIDDLE EAST; VIROLOGY; ZOONOSIS;

ALPHAVIRUS; CHIKUNGUNYA VIRUS;

AEDES; AFRICA; ANIMALS; ASIA; CHIKUNGUNYA FEVER; CHIKUNGUNYA VIRUS; DISEASE OUTBREAKS; EUROPE; GENOTYPE; HUMANS; INSECT VECTORS; MIDDLE EAST; ZOONOSES;

EID: 84928633662     PISSN: 15303667     EISSN: 15577759     Source Type: Journal    
DOI: 10.1089/vbz.2014.1680     Document Type: Article

References (104)

1. Ahola T, Ng L, Hallengärd D, Powers A, et al. Therapeutics and vaccines against chikungunya virus. Vector Borne Zoonotic Dis 2015; 15:250-257.
2. Appassakij H, Khuntikij P, Kemapunmanus M, Wutthanarungsan R, et al. Viremic profiles in asymptomatic and symptomatic chikungunya fever:A blood transfusion threat? Transfusion 2013; 53:2567-2574.
3. Appassakij H, Promwong C, Rujirojindakul P, Wutthanarungsan R, et al. The risk of blood transfusion-associated Chikungunya fever during the 2009 epidemic in Songkhla Province, Thailand. Transfusion 2014; 54:1945-1952.
4. Ayu SM, Lai LR, Chan YF, Hatim A, et al. Seroprevalence survey of Chikungunya virus in Bagan Panchor, Malaysia. Am J Trop Med Hyg 2010; 83:1245-1248.
5. Beesoon S, Funkhouser E, Kotea N, Spielman A, et al. Chikungunya fever, Mauritius, 2006. Emerg Infect Dis 2008; 14:337-338.
6. Blacksell SD, Tanganuchitcharnchai A, Jarman RG, Gibbons RV, et al. Poor diagnostic accuracy of commercial antibody-based assays for the acute diagnosis of chikungunya infection. Clin Vaccine Immunol 2011; 18:1773-1775.
7. Bouquillard E, Combe B. A report of 21 cases of rheumatoid arthritis following Chikungunya fever. A mean follow-up of two years. Joint Bone Spine 2009; 76:654-657.
8. Caminade C, Medlock JM, Ducheyne E, McIntyre KM, et al. Suitability of European climate for the Asian tiger mosquito Aedes albopictus: Recent trends and future scenarios. J R Soc Interface 2012; 9:2708-2717.
9. Carletti F, Bordi L, Chiappini R, Ippolito G, et al. Rapid detection and quantification of Chikungunya virus by a one-step reverse transcription polymerase chain reaction real-time assay. Am J Trop Med Hyg 2007; 77:521-524.
10. Centers for Disease Control and Prevention. Geographic distribution of chikungunya virus. 2015. Available at www.cdc.gov/chikungunya/geo/index.html
11. Chiam CW, Chan YF, Loong SK, Yong SS, et al. Real-time polymerase chain reaction for diagnosis and quantitation of negative strand of chikungunya virus. Diagn Microbiol Infect Dis 2013; 77:133-137.
12. Chipwaza B, Mugasa JP, Selemani M, Amuri M, et al. Dengue and chikungunya fever among viral diseases in outpatient febrile children in Kilosa District Hospital, Tanzania. PLoS Negl Trop Dis 2014; 8:e3335.
13. Chopra A, Anuradha V, Ghorpade R, Saluja M. Acute Chikungunya and persistent musculoskeletal pain following the 2006 Indian epidemic: A 2-year prospective rural community study. Epidemiol Infect 2012; 140:842-850.
14. Chua CL, Chan YF, Sam IC. Characterisation of mouse monoclonal antibodies targeting linear epitopes on Chikungunya virus E2 glycoprotein. J Virol Methods 2014; 195:126-133.
15. Couturier E, Guillemin F, Mura M, Léon L, et al. Impaired quality of life after chikungunya virus infection: A 2-year follow-up study. Rheumatology (Oxford) 2012; 51:1315-1322.
16. Dommar CJ, Lowe R, Robinson M, Rodó X. An agent-based model driven by tropical rainfall to understand the spatio-temporal heterogeneity of a chikungunya outbreak. Acta Trop 2014; 129:61-73.
17. Donoso Mantke O, Niedrig M, ENIVD members. Laboratory capacity for detection of chikungunya virus infections in Europe. Euro Surveill 2007; 12:E070913.2.
18. Dupont-Rouzeyrol M, Caro V, Guillaumot L, Vazeille M, et al. Chikungunya virus and the mosquito vector Aedes aegypti in New Caledonia (South Pacific Region). Vector Borne Zoonotic Dis 2012; 12:1036-1041.
19. Dupuis-Maguiraga L, Noret M, Brun S, Le Grand R, et al. Chikungunya disease: Infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgia. PLoS Negl Trop Dis 2012; 6:e1446.
20. Edwards CJ, Welch SR, Chamberlain J, Hewson R, et al. Molecular diagnosis and analysis of Chikungunya virus. J Clin Virol 2007; 39:271-275.
21. Garcia-Arriaza J, Cepeda V, Hallengärd D, Sorzano CO, et al. A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against chikungunya infection. J Virol 2014; 88:3527-3547.
22. Gasque P, Couderc T, Lecuit M, Roques P, et al. Chikungunya virus pathogenesis and immunity. Vector Borne Zoonotic Dis 2015; 15:241-249.
23. Gérardin P, Barau G, Michault A, et al. Multidisciplinary prospective study of mother-to-child chikungunya virus infections on the island of La Réunion. PLoS Med 2008; 5:e60.
24. Gérardin P, Fianu A, Michault A, Mussard C, et al. Predictors of Chikungunya rheumatism: A prognostic survey ancillary to the TELECHIK cohort study. Arthritis Res Ther 2013; 15:R9.
25. Gläsker S, Lulla A, Lulla V, Couderc T, et al. Virus replicon particle based Chikungunya virus neutralization assay using Gaussia luciferase as readout. Virol J 2013; 10:235.
26. Gould EA, Gallian P, De Lamballerie X, Charrel RN. First cases of autochthonous dengue fever and chikungunya fever in France: From bad dream to reality! Clin Microbiol Infect 2010; 16:1702-1704.
27. Hallengärd D, Kakoulidou M, Lulla A, Kümmerer BM, et al. Novel attenuated chikungunya vaccine candidates elicit protective immunity in C57BL/6 mice. J Virol 2014a; 88:2858-2866.
28. Hallengärd D, Lum FM, Kümmerer BM, Lulla A, et al. Primeboost immunization strategies against chikungunya virus. J Virol 2014b; 88:13333-13343.
29. Ho PS, Ng MM, Chu JJ. Establishment of one-step SYBR green-based real time-PCR assay for rapid detection and quantification of chikungunya virus infection. Virol J 2010; 7:13.
30. Hoarau JJ, Jaffar Bandjee MC, Krejbich Trotot P, Das T, et al. Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response. J Immunol 2010; 184:5914-5927.
31. Horwood P, Bande G, Dagina R, Guillaumot L, et al. The threat of chikungunya in Oceania. Western Pac Surveill Response J 2013a; 4:8-10.
32. Horwood PF, Reimer LJ, Dagina R, Susapu M, et al. Outbreak of chikungunya virus infection, Vanimo, Papua New Guinea. Emerg Infect Dis 2013b; 19:1535-1538.
33. Hussain R, Alomar I, Memish ZA. Chikungunya virus: Emergence of an arthritic arbovirus in Jeddah, Saudi Arabia. East Mediterr Health J 2013; 19:506-508.
34. Institut de Veille Sanitaire. Surveillance sanitaire en Languedoc-Roussillon. Point épidémiologique au 13 novembre, 2014. Available at www.invs.sante.fr/fr/Publications-et-outils/Pointsepidemiologiques/Tous-les-numeros/Languedoc-Roussillon/2014/Surveillance-sanitaire-en-Languedoc-Roussillon.-Point-epidemiologique-au-13-novembre-2014 Accessed November 24, 2014.
35. International Centre for Diarrhoeal Disease Research, Bangladesh. First identified outbreak of Chikungunya in Bangladesh, 2008. Health Sci Bull 2009; 7:1-6.
36. International Society for Infectious Diseases. Chikungunya (51): Singapore, Philippines. ProMED-mail 2013: 20131205.2094593
37. International Society for Infectious Diseases. Chikungunya (27): Tonga, New Caledonia ex Tonga. ProMED-mail 2014a: 20140417.2409660
38. International Society for Infectious Diseases. Chikungunya (27): Tonga, New Caledonia ex Tonga. ProMED-mail 2014b: 20141119.2972276
39. Javelle E, Tiong TH, Leparc-Goffart I, Savini H, et al. Inflammation of the external ear in acute chikungunya infection: Experience from the outbreak in Johor Bahru, Malaysia, 2008. J Clin Virol 2014; 59:270-273.
40. Josseran L, Paquet C, Zehgnoun A, Caillere N, et al. Chikungunya disease outbreak, Reunion Island. Emerg Infect Dis 2006; 12:1994-1995.
41. Kam YW, Lee WW, Simarmata D, Harjanto S, et al. Longitudinal analysis of the human antibody response to Chikungunya virus infection: Implications for serodiagnosis and vaccine development. J Virol 2012a; 86:13005-13015.
42. Kam YW, Lum FM, Teo TH, Lee WW, et al. Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein. EMBO Mol Med 2012b; 4:330-343.
43. Kam YW, Simarmata D, Chow A, Her Z, et al. Early appearance of neutralizing immunoglobulin G3 antibodies is associated with chikungunya virus clearance and long-term clinical protection. J Infect Dis 2012c; 205:1147-1154.
44. Kishishita N, Takeda N, Anuegoonpipat A, Anantapreecha S. Development of a pseudotyped-lentiviral-vector-based neutralization assay for chikungunya virus infection. J Clin Microbiol 2013; 51:1389-1395.
45. Kosasih H, de Mast Q, Widjaja S, Sudjana P, et al. Evidence for endemic chikungunya virus infections in Bandung, Indonesia. PLoS Negl Trop Dis 2013; 7:e2483.
46. Kowalzik S, Xuan NV, Weissbrich B, Scheiner B, et al. Characterisation of a chikungunya virus from a German patient returning from Mauritius and development of a serological test. Med Microbiol Immunol 2008; 197:381-386.
47. Lanciotti RS, Valadere AM. Transcontinental movement of Asian genotype chikungunya virus. Emerg Infect Dis 2014; 20:1400-1402.
48. Lanciotti RS, Kosoy OL, Laven JJ, Panella AJ, et al. Chikungunya virus in US travelers returning from India, 2006. Emerg Infect Dis 2007; 13:764-767.
49. Laurent P, Le Roux K, Grivard P, Bertil G, et al. Development of a sensitive real-time reverse transcriptase PCR assay with an internal control to detect and quantify chikungunya virus. Clin Chem 2007; 53:1408-1414.
50. Lee VJ, Chow A, Zheng X, Carrasco LR, et al. Simple clinical and laboratory predictors of Chikungunya versus dengue infections in adults. PLoS Negl Trop Dis 2012; 6:e1786.
51. Lemant J, Boisson V, Winer A, Thibault L, et al. Serious acute chikungunya virus infection requiring intensive care during the Reunion Island outbreak in 2005-2006. Crit Care Med 2008; 36:2536-2341.
52. Leparc-Goffart I, Nougairede A, Cassadou S, Prat C, et al. Chikungunya in the Americas. Lancet 2014; 383:514.
53. Liew C, Yung CF. First detection of chikungunya infection and transmission in Brunei Darussalam. Singapore Med J 2012; 53:e66-68.
54. Litzba N, Schuffenecker I, Zeller H, Drosten C, et al. Evaluation of the first commercial chikungunya virus indirect immunofluorescence test. J Virol Methods 2008; 149:175-179.
55. Mahendradas P, Avadhani K, Shetty R. Chikungunya and the eye: A review. J Ophthalmic Inflamm Infect 2013; 3:35.
56. Manimunda SP, Vijayachari P, Uppoor R, Sugunan AP, et al. Clinical progression of chikungunya fever during acute and chronic arthritic stages and the changes in joint morphology as revealed by imaging. Trans Roy Soc Trop Med Hyg 2010; 104:392-399.
57. Marimoutou C, Vivier E, Oliver M, Boutin JP, et al. Morbidity and impaired quality of life 30 months after chikungunya infection: Comparative cohort of infected and uninfected French military policemen in Reunion Island. Medicine (Baltimore) 2012; 91:212-219.
58. Mavalankar D, Shastri P, Bandyopadhyay T, Parmar J, et al. Increased mortality rate associated with chikungunya epidemic, Ahmedabad, India. Emerg Infect Dis 2008; 14:412-415.
59. Mohd Zim MA, Sam IC, Omar SF, Chan YF, et al. Chikungunya infection in Malaysia: Comparison with dengue infection in adults and predictors of persistent arthralgia. J Clin Virol 2013; 56:141-145.
60. Moro ML, Grilli E, Corvetta A, Silvi G, et al. Long-term chikungunya infection clinical manifestations after an outbreak in Italy: A prognostic cohort study. J Infect 2012; 65:165-172.
61. Muniaraj M. Fading chikungunya fever from India: Beginning of the end of another episode? Indian J Med Res 2014; 139:468-470.
62. Nitatpattana N, Kanjanopas K, Yoksan S, Satimai W, et al. Long-term persistence of Chikungunya virus neutralizing antibodies in human populations of North Eastern Thailand. Virol J 2014; 11:183.
63. Nkoghe D, Kassa RF, Caron M, Grard G, et al. Clinical forms of chikungunya in Gabon, 2010. PLoS Negl Trop Dis 2012; 6:e1517.
64. Okabayashi T, Sasaki T, Masrinoul P, Chantawat N. Detection of chikungunya virus antigen by a novel rapid immunochromatographic test. J Clin Microbiol 2014; 53:382-388.
65. Pan American Health Organization. Number of reported cases of chikungunya fever in the Americas. 2015. Available at http://www.paho.org/hq/index.php?option = com-topics&view=article&id = 343&Itemid = 40931
66. Panning M, Hess M, Fischer W, Grywna K, et al. Performance of the RealStar Chikungunya virus real-time reverse transcription-PCR kit. J Clin Microbiol 2009; 47:3014-3016.
67. Parida MM, Santhosh SR, Dash PK, Tripathi NK, et al. Rapid and real-time detection of Chikungunya virus by reverse transcription loop-mediated isothermal amplification assay. J Clin Microbiol 2007; 45:351-357.
68. Parida, MM, Santhosh SR, Dash PK, Lakshmana Rao PV. Rapid and real-time assays for detection and quantification of Chikungunya virus. Future Virol 2008; 3:179-192.
69. Pastorino B, Bessaud M, Grandadam M, Murri S, et al. Development of a TaqMan RT-PCR assay without RNA extraction step for the detection and quantification of African Chikungunya viruses. J Virol Methods 2005; 124:65-71.
70. Pavri K. Disappearance of Chikungunya virus from India and South East Asia. Trans R Soc Trop Med Hyg 1986; 80:491.
71. Plaskon NE, Adelman ZN, Myles KM. Accurate strand-specific quantification of viral RNA. PLoS One 2009; 4:e7468.
72. Prat CM, Flusin Ol Panella A, Tenebray B, et al. Evaluation of commercially available serologic diagnostic tests for chikungunya virus. Emerg Infect Dis 2014; 20:2129-2132.
73. Ramful D, Sampériz S, Fritel X, Michault A, et al. Antibody kinetics in infants exposed to chikungunya virus infection during pregnancy reveals absence of congenital infection. J Infect Dis 2014; 209:1726-1730.
74. Reddy V, Ravi V, Desai A, Parida M, et al. Utility of IgM ELISA, TaqMan real-time PCR, reverse transcription PCR, and RT-LAMP assay for the diagnosis of Chikungunya fever. J Med Virol 2012; 84:1771-1778.
75. Renault P, Balleydier E, D'Ortenzio E, Bâville M, et al. Epidemiology of Chikungunya infection on Reunion Island, Mayotte, and neighboring countries. Med Mal Infect 2012; 42:93-101.
76. Rezza G, Nicoletti L, Angelini R, Romi R, et al. Infection with chikungunya virus in Italy: An outbreak in a temperate region. Lancet 2007; 370:1840-1846.
77. Robinson M, Conan A, Duong V, Ly S, et al. A model for a chikungunya outbreak in a rural Cambodian setting: implications for disease control in uninfected areas. PLOS Negl Trop Dis 2014; 8:e3120.
78. Robinson MC. An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53 - 1: Clinical features. Trans R Soc Trop Med Hyg 1955; 49:28-32.
79. Rougeron V, Sam IC, Caron M, Nkoghe D, et al. Chikungunya, a paradigm of neglected tropical disease that emerged to be a new health global risk. J Clin Virol 2014; 64:144-152.
80. Sam IC, Chan YF, Chan SY, Loong SK, et al. Chikungunya virus of Asian and Central/East African genotypes in Malaysia. J Clin Virol 2009; 46:180-183.
81. Sam IC, Chua CL, Chan YF. Chikungunya virus diagnosis in the developing world: A pressing need. Expert Rev Anti Infect Ther 2011; 9:1089-1091.
82. Sam IC, Loong SK, Michael JC, Chua CL, et al. Genotypic and phenotypic characterization of Chikungunya virus of different genotypes from Malaysia. PLoS One 2012; 7:e50476.
83. Schilte C, Staikowsky F, Couderc T, Madec Y, et al. Chikungunya virus-associated long-term arthralgia: A 36-month prospective longitudinal study. PLoS Negl Trop Dis 2013; 7:e2137.
84. Sebastian MR, Lodha R, Kabra SK. Chikungunya infection in children. Indian J Pediatr 2009; 76:185-189.
85. Shenoy S, Pradeep GC. Neurodevelopmental outcome of neonates with vertically transmitted Chikungunya fever with encephalopathy. Indian Pediatr 2012; 49:238-240.
86. Soulaphy C, Souliphone P, Phanthavong K, Phonekeo D, et al. Emergence of chikungunya in Moonlapamok and Khong Districts, Champassak Province, the Lao People's Democratic Republic, May to September 2012. Western Pac Surveill Response J 2013; 4:46-50.
87. Tan JL, Capozzoli M, Mitsuharu S, Watthanaworawit W, et al. An integrated lab-on-chip for rapid identification and simultaneous differentiation of tropical pathogens. PLoS Negl Trop Dis 2014; 8:e3043.
88. Thiberville SD, Boisson V, Gaudart J, Simon F, et al. Chikungunya fever: A clinical and virological investigation of outpatients on Reunion Island, South-West Indian Ocean. PLoS Negl Trop Dis 2013a; 7:e2004.
89. Thiberville SD, Moyen N, Dupuis-Maguiraga L, Nougairede A, et al. Chikungunya fever: Epidemiology, clinical syndrome, pathogenesis and therapy. Antivir Res 2013b; 99: 345-370.
90. Tsetsarkin KA, Chen R, Sherman MB, Weaver SC. Chikungunya virus: Evolution and genetic determinants of emergence. Curr Opin Virol 2011; 1:310-317.
91. Tsetsarkin KA, Chen R, Yun R, Rossi SL, et al. Multi-peaked adaptive landscape for chikungunya virus evolution predicts continued fitness optimization in Aedes albopictus mosquitoes. Nat Commun 2014; 5:4084.
92. Ummul Haninah A, Vasan SS, Ravindran T, Chandru A, et al. Development and evaluation of a one-step SYBR-Green I-based real-time RT-PCR assay for the detection and quantification of Chikungunya virus in human, monkey and mosquito samples. Trop Biomed 2010; 27:611-623.
93. Valamparampil JJ, Chirakkarot S, Letha S, Jayakumar C, et al. Clinical profile of Chikungunya in infants. Indian J Pediatr 2009; 76:151-155.
94. Vega-Rúa A, Zouache K, Girod R, Failloux AB, et al. High level of vector competence of Aedes aegypti and Aedes albopictus from ten American countries as a crucial factor in the spread of Chikungunya virus. J Virol 2014; 88:6294-6306.
95. Volk SM, Chen R, Tsetsarkin KA, Adams AP, et al. Genome-scale phylogenetic analyses of chikungunya virus reveal independent emergences of recent epidemics and various evolutionary rates. J Virol 2010; 84:6497-6504.
96. Voss JE, Vaney MC, Duquerroy S, Vonrhein C, et al. Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography. Nature 2010; 468:709-712.
97. Wangchuk S, Chinnawirotpisan P, Dorji T, Tobgay T, et al. Chikungunya fever outbreak, Bhutan, 2012. Emerg Infect Dis 2013; 19:1681-1684.
98. Wanlapakorn N, Thongmee T, Linsuwanon P, Chattakul P, et al. Chikungunya outbreak in Bueng Kan Province, Thailand, 2013. Emerg Infect Dis 2014; 20:1404-1406.
99. Warter L, Lee CY, Thiagarajan R, Grandadam M, et al. Chikungunya virus envelope-specific human monoclonal antibodies with broad neutralization potency. J Immunol 2011; 186:3258-3264.
100. Waymouth HE, Zoutman DE, Towheed TE. Chikungunya-related arthritis: Case report and review of the literature. Semin Arthritis Rheum 2013; 43:273-278.
101. World Health Organization, Regional Office for South-East Asia. Guidelines for prevention and control of chikungunya fever. India: WHO, 2009.
102. Yap G, Pok KY, Lai YL, Hapuarachchi HC, et al. Evaluation of chikungunya diagnostic assays: differences in sensitivity of serology assays in two independent outbreaks. PLoS Negl Trop Dis 2010; 4:e753.
103. Zayed A, Awash AA, Esmail MA, Al-Mohamadi HA, et al. Detection of Chikungunya virus in Aedes aegypti during 2011 outbreak in Al Hodayda, Yemen. Acta Trop 2012; 123:62-66.
104. Zheng K, Li J, Zhang Q, Liang M, et al. Genetic analysis of chikungunya viruses imported to mainland China in 2008. Virol J 2010; 7:8.